Stem cell therapy is a non-surgical option for minor herniated disks and early degeneration. It uses mesenchymal stem cells to reduce inflammation and promote biological repair. While it avoids invasive incisions, it remains an alternative only for specific structural cases without severe nerve compression.
- Treatment mechanism: Injections aim to repair tissues biologically rather than through mechanical stabilization.
- Regulatory framework: COFEPRIS guidelines in Mexico allow for expanded cell counts up to 300 million.
- Ideal candidates: Patients with degenerative disk disease or sciatica often see the best results.
- Recovery timeline: full benefits usually appear between 6 and 12 months post-procedure.
Bookimed Expert Insight: Data from high-volume centers like GDL High Specialty Neurosurgery, which serves nearly 700 patients annually, suggests that successful outcomes depend on precise diagnostics. We see that top neurosurgeons like Dr. Roberto Hernandez-pena often combine Mexican training with international fellowships to bridge the gap between regenerative and surgical expertise. This dual-specialization ensures patients only receive stem cells when structural integrity allows for non-mechanical repair.
Patient Consensus: Many patients note that while injections provided short-term relief, they advise getting independent MRIs to track actual disk regeneration. There is a strong emphasis on verifying clinic credentials to avoid overly aggressive marketing tactics for unproven treatments.